Special Bulletin
The ºÚÁÏÕýÄÜÁ¿ Association (AHA) sends members Special Bulletins on the latest health care news, legislation, and advocacy opportunities for hospitals and health systems.
The Centers for Medicare & Medicaid Services (CMS) Nov. 1 released its calendar year (CY) 2025 outpatient prospective payment system (OPPS) and ambulatory surgical center (ASC) final rule. The rule increases OPPS rates by a net 2.9% in CY 2025 compared to CY 2024.
As part of its efforts to mitigate the disruption to the supply of IV solutions after Hurricane Helene temporarily closed its North Cove, N.C., manufacturing plant, Baxter today said that it is now authorized by the Food and Drug Administration (FDA) to extend the use date of some products to…
Baxter this week shared updates on its efforts to increase access to and supply of IV solutions in response to the effects of Hurricane Helene on Baxter’s manufacturing facility in North Carolina.
The Centers for Medicare & Medicaid Services (CMS) yesterday released interpretive guidance providing additional details for the hospital respiratory data condition of
participation (CoP).
The AHA in partnership with the FBI today released a new resource and webpage on mitigating targeted violence in health care settings.
The Department of Health and Human Services (HHS) and Baxter officials have announced additional actions to increase access and supply of IV solutions in response to the effects of Hurricane Helene on Baxter’s manufacturing facility in North Carolina. HHS’ mitigation efforts include increasing…
The Centers for Disease Control and Prevention (CDC), in an Oct. 16 webinar, provided updates on the new hospital respiratory data condition of participation (CoP).
Hospital and health system leaders are invited to participate in a call hosted by Department of Health and Human Services Secretary Xavier Becerra tomorrow, Oct. 18 at 1:30 p.m. ET to hear updates about the response to the effects of Hurricane Helene on Baxter's manufacturing facility in North…
The Food and Drug Administration (FDA) today released guidance that is effective immediately for compounding certain parenteral drug products in response to the effects of recent hurricanes, including the closure of a Baxter manufacturing plant in North Carolina.
On a call today hosted by Department of Health and Human Services Secretary Xavier Becerra, officials from the federal government and Baxter provided updates on the ongoing efforts to address the IV solution supply disruptions caused by the temporary closure of a Baxter manufacturing plant in North…